Safety of irinotecan and infusional fluorouracil/leucovorin (FOLFIRI) in Japan : a retrospective review of 48 patients with metastatic colorectal cancer

• FUSE Nozomu

  Division of Gastrointestinal Oncology and Digestive Endoscopy, National Cancer Center Hospital East

• DOI Toshihiko

  Division of Gastrointestinal Oncology and Digestive Endoscopy, National Cancer Center Hospital East

• OHTSU Atsushi

  Division of Gastrointestinal Oncology and Digestive Endoscopy, National Cancer Center Hospital East

• YANO Tomonori

  Division of Gastrointestinal Oncology and Digestive Endoscopy, National Cancer Center Hospital East

• HAMAMOTO Yasuo

  Division of Gastrointestinal Oncology and Digestive Endoscopy, National Cancer Center Hospital East

• MINASHI Keiko

  Division of Gastrointestinal Oncology and Digestive Endoscopy, National Cancer Center Hospital East

• TAHARA Makoto

  Division of Gastrointestinal Oncology and Digestive Endoscopy, National Cancer Center Hospital East

• MUTO Manabu

  Division of Gastrointestinal Oncology and Digestive Endoscopy, National Cancer Center Hospital East

• ASAKA Masahiro

  Department of Gastroenterology, Hokkaido University Graduate School of Medicine

• YOSHIDA Shigeaki

  Division of Gastrointestinal Oncology and Digestive Endoscopy, National Cancer Center Hospital East

Journal

• Int J Clin Oncol

  Int J Clin Oncol 13 (2), 144-149, 2008-04-01

Keywords

• FOLFIRI
• Colorectal cancer
• Irinotecan
• Safety
• Feasibility

Details

• CRID: 1572261550589326976
• NII Article ID: 10024142052
• NII Book ID: AA11086579
• ISSN: 13419625
• Web Site: https://search.jamas.or.jp/link/ui/2008308502
• Text Lang: en
• Data Source:
  • CiNii Articles